Skip to content
ppharmaranks
Menu

The pill imprinted “G17

The imprint G17 appears on 5 different products in the FDA data: Naproxen Sodium Diphenhydramine HCL 25 mg / 220 mg, Naproxen Sodium Diphenhydramine HCl 220 mg / 25 mg, Naproxen Sodium Diphenhydramine Hydrochloride 220 mg / 25 mg, Naproxen Sodium and Diphenhydramine HCL 25 mg / 220 mg, and more. Match the colour and shape below to your pill.

By the pharmaranks editorial teamReviewed against the U.S. FDA / DailyMed (Structured Product Labeling) sourcesHow we research
  • Naproxen Sodium Diphenhydramine HCL25 mg / 220 mg
    Imprint G;17 · Blue · Capsule · 15 mm · Tablet
    NDC 79903-204
    Imprint match
  • Naproxen Sodium Diphenhydramine HCl220 mg / 25 mg
    Imprint G;17 · Blue · Oval · 15 mm · Tablet, film coated
    Generic: Naproxen Sodium Diphenhydramine HCl
    NDC 69842-328
    Imprint match
  • Naproxen Sodium Diphenhydramine Hydrochloride220 mg / 25 mg
    Imprint G;17 · Blue · Capsule · 15 mm · Tablet
    NDC 21130-814
    Imprint match
  • Naproxen Sodium and Diphenhydramine HCL25 mg / 220 mg
    Imprint G;17 · Blue · Capsule · 15 mm · Tablet
    NDC 11673-819
    Imprint match
  • Naproxen Sodium and Diphenhydramine HCl220 mg / 25 mg
    Imprint G;17 · Blue · Capsule · 15 mm · Tablet, film coated
    NDC 62207-814
    Imprint match
  • Before you rely on this

    A pill’s appearance varies between manufacturers and generic versions, imprints wear off, and two different drugs can share an imprint. Everything here is transcribed straight from the FDA’s DailyMed labels — we do not alter or infer it — but treat any identification as a starting point and confirm with a licensed pharmacist before taking or discarding a medication.

    Wrong pill? Search by imprint, colour and shape in the full pill identifier.

    Source: the U.S. National Library of Medicine’s DailyMed Structured Product Labeling — the FDA-required drug labels. Imprint, colour, shape, size and score are transcribed, not inferred. This is reference information, not medical advice.